571 Staphylococcal Lipopeptide Induces Beta-Catenin to Suppress TLR3-mediated Skin Inflammation in Diabetes

D. Li,Y. Lai

DOI: https://doi.org/10.1016/j.jid.2017.02.593

2017-01-01

Abstract:Dysregulated inflammatory responses are known to impair wound healing, but whether skin commensal Staphylococcus epidermidis would regulate these inflammatory responses to promote wound healing remains unclear. Here we show that lipopeptide 78 (LP78), a novel lipopeptide we identified from Staphylococcus epidermidis, inhibited TLR3-mediated skin inflammation to promote wound healing in diabetes. Skin injury increased the expression of TNF-α and IL-6 in diabetes. This induction was dependent on TLR3 activation as TLR3 deficiency significantly decreased the expression of TNF-α and IL-6 in diabetic skin wounds. The activation of TLR3 by its ligand poly(I:C) induced p65 translocation into nuclei, and then p65 interacted with PPARγ to induce the inflammatory response in keratinocytes. LP78 induced β-catenin expression and activation to inhibit this interaction via competing with p65 binding to PPARγ, thus inhibiting TLR3-induced inflammatory cytokine expression to promote wound healing. The anti-inflammatory effect of LP78 was depended on TLR2-CD14/CD36 receptor as LP78 did not inhibit TLR3-indcued inflammation in Tlr2-deficient mice or lost its capacity to inhibit inflammatory response after CD14/CD36 was knocked down. Taken together, our results show that lipopetide LP78 from skin commensal Staphylococcus epidermidis inhibits TLR3-mediated skin inflammation via the induction of β-catenin to compete with p65 binding to PPARγ, thus regulating the inflammatory response to promote wound healing.